TRT (Testosterone Replacement Therapy): Diagnosis, Treatment Options, and What to Expect

If you have been dragging through your days, losing interest in things that used to fire you up, watching your body change in ways that don’t match your effort in the gym, or just feeling like a shadow of who you used to be, you are not alone. Millions of men walk around with testosterone levels that are too low to support normal function, and most of them have no idea that a treatable hormone deficiency is behind it.

Testosterone replacement therapy, commonly called TRT, is one of the most talked-about treatments in men’s health right now. But the conversation is full of noise. Bro-science on one side, overly cautious dismissals on the other. This guide sits in the middle, grounded in published research and clinical guidelines, so you can make an informed decision about whether TRT is right for you.

What Is Testosterone Replacement Therapy?

TRT is the medical practice of restoring testosterone to normal physiological levels in men whose bodies no longer produce enough on their own. It is not about pushing testosterone into supraphysiological ranges. The goal is to bring levels back to where they should be, typically between 450 and 700 ng/dL for most men, though some clinicians target ranges up to 900 ng/dL depending on symptoms and individual response [1].

Testosterone is the primary male sex hormone. It plays a role in muscle mass, fat distribution, bone density, red blood cell production, sex drive, sperm production, and mood regulation. When levels drop below the threshold needed to support these functions, the effects show up across nearly every system in the body.

The medical term for clinically low testosterone is hypogonadism. It can be primary (the testes themselves fail to produce enough testosterone) or secondary (the pituitary gland or hypothalamus fails to signal the testes properly). TRT addresses the end result of both: not enough testosterone in circulation [2].

Symptoms of Low Testosterone

Low testosterone does not always look the same from one man to the next. Some men notice a dramatic shift in how they feel. Others experience a slow, creeping decline over years that they chalk up to aging. Here are the most common symptoms:

• Persistent fatigue that does not improve with sleep or rest
• Low libido or a noticeably reduced interest in sex
• Erectile dysfunction or difficulty maintaining erections
• Mood changes including irritability, low motivation, and depressive symptoms
• Loss of muscle mass despite consistent training
• Increased body fat, especially around the midsection
• Brain fog and difficulty concentrating or remembering things
• Decreased motivation and a loss of drive or competitive edge
• Reduced bone density, which can increase fracture risk over time
• Sleep disturbances unrelated to other identifiable causes
• Hot flashes or night sweats in some men with very low levels

One or two of these symptoms in isolation does not necessarily mean low testosterone. But when several of them cluster together, especially in men over 30, it is worth getting bloodwork done [3].

How Low Testosterone Is Diagnosed

A proper diagnosis of hypogonadism is not based on a single lab result. Guidelines from the American Urological Association (AUA) and the Endocrine Society require at least two separate morning blood draws showing low testosterone, combined with clinical symptoms [1].

Why morning draws? Testosterone follows a circadian rhythm and peaks in the early morning hours, typically between 7 and 10 AM. Testing later in the day may show artificially low numbers. Two draws are required to rule out transient dips caused by stress, poor sleep, illness, or other temporary factors.

Key Labs for Diagnosis

• Total testosterone – the overall amount of testosterone in your blood, both bound and unbound. Most labs flag levels below 264-300 ng/dL as low, though many men experience symptoms at levels well above that cutoff.
• Free testosterone – the small fraction (about 2-3%) of testosterone that is unbound and biologically active. This can be low even when total T is borderline normal.
• Sex hormone-binding globulin (SHBG) – a protein that binds testosterone and makes it unavailable. High SHBG can cause low free T despite normal total T.
• Luteinizing hormone (LH) – helps distinguish primary from secondary hypogonadism. High LH with low T suggests the testes are failing. Low or normal LH with low T points to a brain-level problem.
• Follicle-stimulating hormone (FSH) – works alongside LH to assess the hypothalamic-pituitary-gonadal axis.
• Prolactin – elevated prolactin can suppress testosterone production and may indicate a pituitary issue.
• Comprehensive metabolic panel – rules out liver or kidney dysfunction that could affect hormone metabolism.
• Estradiol (E2) – important baseline, as some testosterone converts to estrogen via aromatase.
• Complete blood count (CBC) – establishes a baseline hematocrit before treatment.

A thorough clinician will also assess thyroid function, cortisol, vitamin D, and ferritin, because deficiencies in any of these can mimic or worsen low testosterone symptoms [4].

Types of TRT

There is no single best form of testosterone replacement. The right choice depends on your lifestyle, preferences, how your body responds, and what your provider is comfortable prescribing. Here is what is available.

Intramuscular and Subcutaneous Injections

Injections are the most widely prescribed and most cost-effective form of TRT. The two most common esters are testosterone cypionate and testosterone enanthate. Both are dissolved in oil (typically cottonseed or sesame oil) and injected either intramuscularly (into the glute or deltoid) or subcutaneously (into abdominal fat).

Most protocols involve injecting once or twice per week. More frequent, smaller doses tend to produce more stable blood levels and fewer side effects than the older practice of injecting a large dose every two weeks, which creates peaks and valleys that some men feel acutely [5].

Typical starting doses range from 100 to 200 mg per week, adjusted based on follow-up blood work and symptom response. Many men learn to self-inject at home after initial training from their provider.

Topical Gels and Creams

Topical testosterone is applied daily to the skin, usually on the shoulders, upper arms, or inner thighs. Brand names include AndroGel and Testim (gels) and various compounded creams. Absorption varies between individuals. Some men do well on topicals, while others struggle to absorb enough to reach therapeutic levels.

The main drawback is the risk of transference. If a partner, child, or pet contacts the application site before it fully dries, they can absorb testosterone through their skin. This is a serious concern in households with women and children [6].

Subcutaneous Pellets

Testosterone pellets (brand name Testopel) are small, rice-sized cylinders implanted under the skin of the hip or buttock during an in-office procedure. They dissolve slowly over 3 to 6 months, providing steady testosterone release without daily or weekly dosing.

The advantage is convenience. The disadvantage is that once implanted, the dose cannot be adjusted until the pellets dissolve. If levels run too high or too low, you are stuck with them. Pellet extrusion (the pellet working its way back out through the skin) is an occasional complication [7].

Nasal Gel

Natesto is a testosterone nasal gel applied inside the nostrils two to three times daily. It produces short-lived spikes in testosterone, which some proponents argue may better mimic the body’s natural pulsatile release. One potential advantage: nasal testosterone may have less impact on sperm production than other forms, making it a consideration for men concerned about fertility [8].

The downsides include the inconvenience of multiple daily applications and nasal irritation in some users.

Oral Testosterone

Oral testosterone undecanoate (brand name Jatenzo) was FDA-approved in 2019. Unlike older oral formulations that were harsh on the liver, Jatenzo is absorbed through the lymphatic system, bypassing first-pass liver metabolism. It is taken twice daily with food.

While it addresses the liver toxicity concern, oral testosterone can raise blood pressure in some patients and requires twice-daily dosing, which some men find less convenient than weekly injections [9].

Benefits of TRT

When testosterone levels are genuinely low and TRT is properly managed, the benefits can be significant. Research and clinical experience support improvements in the following areas:

Energy and vitality. Fatigue is often the first symptom to improve. Many men report feeling more alert, more motivated, and more capable of sustaining effort throughout the day within the first few weeks of treatment [10].

Sexual function. Libido typically increases, and erectile function often improves, particularly in men whose ED is hormone-related rather than vascular. The Testosterone Trials (TTrials) showed significant improvement in sexual desire and erectile function in older men with low T [10].

Body composition. TRT promotes lean muscle growth and reduces fat mass. A meta-analysis found that testosterone therapy increased lean body mass by an average of 1.6 kg and reduced fat mass by 2 kg [11].

Mood and mental health. Irritability, low motivation, and depressive symptoms frequently improve. This is not the same as treating clinical depression with testosterone, but in men whose mood symptoms are driven by low T, the effect can be meaningful [12].

Bone density. Testosterone stimulates bone formation and slows bone resorption. The TTrials demonstrated increased bone mineral density and estimated bone strength in the spine and hip with one year of testosterone treatment [13].

Cognitive function. Some studies suggest improvements in spatial memory and verbal fluency, though the cognitive benefits of TRT are still being studied and results have been mixed [10].

Risks and Side Effects of TRT

TRT is not a risk-free treatment. Responsible use requires understanding the potential downsides and committing to regular monitoring.

Polycythemia (Elevated Red Blood Cells)

This is the most common side effect. Testosterone stimulates erythropoiesis (red blood cell production), which can push hematocrit above safe levels. Elevated hematocrit thickens the blood and increases the risk of blood clots, stroke, and other cardiovascular events. Most clinicians want hematocrit to stay below 54%. If it climbs too high, the standard intervention is therapeutic phlebotomy (blood donation) or a dose reduction [14].

Acne and Oily Skin

Testosterone increases sebum production, which can trigger acne, particularly on the back and shoulders. This is more common in the early months of treatment and often settles down. Topical treatments or dose adjustments usually manage it.

Hair Loss

In men genetically predisposed to male-pattern baldness, TRT can accelerate hair loss. Testosterone converts to dihydrotestosterone (DHT) via the enzyme 5-alpha reductase, and DHT is the primary driver of androgenetic alopecia. Some men use low-dose finasteride to block this conversion, though this should be discussed with a provider.

Sleep Apnea

TRT may worsen obstructive sleep apnea in men who already have it, or in rare cases, trigger it in men who are predisposed. Any man starting TRT should be screened for sleep apnea, and those already using CPAP should be monitored closely [1].

Testicular Atrophy

When you supply testosterone from an external source, the brain detects adequate levels and stops sending the signal (LH and FSH) for the testes to produce their own. Over time, the testes can shrink. This is reversible if TRT is stopped, but it takes time. Concurrent HCG therapy can prevent or reduce atrophy by maintaining intratesticular testosterone production.

Cardiovascular Risk

The cardiovascular safety of TRT has been one of the most debated topics in endocrinology. A 2013 observational study raised alarm by suggesting increased cardiovascular events in men on TRT. However, the TRAVERSE trial, a large randomized controlled trial published in 2023, found that testosterone replacement did not increase the incidence of major adverse cardiovascular events compared to placebo in middle-aged and older men with hypogonadism and preexisting or high risk of cardiovascular disease [15].

The current consensus is that TRT at physiological doses does not appear to increase cardiovascular risk in appropriately selected patients, but ongoing monitoring remains important.

TRT and Fertility

This is one of the most important and most misunderstood aspects of testosterone therapy. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which dramatically reduces or eliminates sperm production. For men who want to have children, starting TRT without a fertility preservation strategy can be a serious problem.

HCG (Human Chorionic Gonadotropin)

HCG mimics LH and stimulates the testes to continue producing testosterone and sperm even while on exogenous testosterone. Many TRT clinics co-prescribe HCG at doses of 500-1000 IU two to three times per week specifically to maintain fertility and prevent testicular atrophy. It is worth noting that HCG availability has been affected by FDA regulatory changes that reclassified it as a biologic, making it harder to obtain from compounding pharmacies [16].

Clomiphene Citrate

Clomiphene is a selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the hypothalamus, causing the brain to increase LH and FSH production. This stimulates the testes to produce more testosterone endogenously. It is used off-label in men as an alternative to TRT, particularly in younger men who want to preserve fertility. It can raise testosterone levels by 200-400 ng/dL in many patients [17].

The downside is that clomiphene does not work for everyone, and some men report that the subjective improvements in symptoms are not as strong as with direct testosterone replacement.

Enclomiphene

Enclomiphene is the trans-isomer of clomiphene and is considered the more pharmacologically active component. It raises testosterone while preserving or improving sperm parameters. Though not yet FDA-approved as of this writing, it is available through some compounding pharmacies and is gaining traction in men’s health clinics as a TRT alternative for men who want hormonal optimization without fertility suppression [18].

TRT vs. Clomiphene vs. Enclomiphene

Each approach has trade-offs. Here is a straightforward comparison:

• TRT (injections, gel, pellets): Most effective at raising testosterone and resolving symptoms. Suppresses natural production. Impairs fertility. Requires commitment to ongoing treatment. Most men report feeling the best on direct testosterone.
• Clomiphene: Raises testosterone by stimulating natural production. Preserves fertility. Symptom relief is less consistent. Can cause visual disturbances, mood changes, or elevated estradiol in some men.
• Enclomiphene: Similar to clomiphene but potentially fewer side effects due to its more targeted mechanism. Preserves fertility. Still being studied for long-term outcomes.

For men in their 20s and 30s who may want children, starting with clomiphene or enclomiphene makes sense as a first step. For men who have completed their families or are not concerned about fertility, direct TRT typically provides the strongest symptom relief.

Monitoring While on TRT

Responsible TRT requires regular blood work. Most providers check labs at 6 weeks, 3 months, 6 months, and then every 6 to 12 months once stable. Key markers include:

• Total and free testosterone – to confirm levels are in the therapeutic range
• Hematocrit and hemoglobin – to catch polycythemia early
• Estradiol (E2) – testosterone aromatizes to estrogen, and elevated estradiol can cause water retention, gynecomastia, mood issues, and blunted libido
• Prostate-specific antigen (PSA) – TRT does not cause prostate cancer, but it can stimulate growth of existing prostate tissue, so PSA should be monitored
• Lipid panel – testosterone can affect HDL and LDL cholesterol levels
• Liver function tests – especially important for men on oral testosterone or those with pre-existing liver conditions
• Comprehensive metabolic panel – kidney function, electrolytes, and glucose

If hematocrit rises above 54%, most guidelines recommend dose reduction or therapeutic phlebotomy. If estradiol climbs and symptoms appear, some clinicians prescribe a low-dose aromatase inhibitor (anastrozole), though this practice is controversial and carries its own risks including bone density loss [14].

TRT in Women

While TRT is primarily associated with men, there is growing interest and emerging evidence for testosterone therapy in women, particularly for hypoactive sexual desire disorder (HSDD). Women produce testosterone in the ovaries and adrenal glands, and levels decline with age, especially after menopause.

A 2019 global position statement endorsed testosterone therapy for postmenopausal women with HSDD at doses that maintain testosterone within the normal premenopausal range. The statement noted improvements in sexual desire, arousal, orgasm, and satisfaction. Importantly, the doses used in women are a fraction of male doses, typically 5-10 mg per day in cream or gel form [19].

This is still an emerging area, and long-term safety data in women is limited. Any woman considering testosterone therapy should work with a provider experienced in female hormones.

Finding a TRT Provider

Not all providers approach testosterone therapy the same way. Here are the main options:

Urologists

Urologists often have the deepest experience with male hormones, particularly in the context of sexual function, fertility, and prostate health. A fellowship-trained reproductive urologist is an excellent choice for men who have fertility concerns alongside low T.

Endocrinologists

Endocrinologists specialize in the hormonal system broadly. They are well-equipped to diagnose the underlying cause of hypogonadism (primary vs. secondary, pituitary tumors, etc.) and manage complex cases. However, some endocrinologists are conservative about prescribing TRT and may have long wait times.

TRT Clinics and Telemedicine

Men’s health clinics and telehealth TRT providers have proliferated in recent years. They tend to be more accessible and more willing to prescribe than traditional providers. The quality varies widely. The best clinics provide thorough lab work, individualized protocols, and regular follow-up. The worst are essentially pill mills with minimal oversight.

Red flags to watch for: any provider who prescribes TRT without baseline blood work, anyone who refuses to monitor labs after starting treatment, and clinics that push expensive proprietary protocols without transparent pricing.

Cost of TRT

The cost depends on the delivery method, insurance coverage, and whether you use a brand-name or generic product.

• Testosterone cypionate or enanthate (generic, injectable): $30-80 per month without insurance. This is by far the most affordable option.
• Topical gels (brand name): $200-500 per month without insurance, though generic and compounded options bring this down to $50-150.
• Pellets: $500-1,000 per insertion every 3-6 months, averaging roughly $100-300 per month.
• HCG (if co-prescribed): Adds $30-100 per month depending on the source.
• Lab work: $100-300 per panel, typically needed 2-4 times per year.

Most men spend between $50 and $200 per month on TRT when using injectable testosterone, including supplies. Insurance coverage varies. Many plans cover TRT when there is a confirmed diagnosis of hypogonadism. TRT clinics that do not accept insurance tend to cost more upfront but may be more flexible with protocols.

Stopping TRT

Stopping testosterone replacement therapy is possible, but it should be done with medical guidance, not cold turkey. When you discontinue exogenous testosterone, your body needs time to restart its own production. For some men, natural production recovers within weeks to months. For others, particularly those who have been on TRT for years, recovery can be slow or incomplete.

A typical post-TRT recovery protocol might include:

• HCG to stimulate testicular function before and during the taper
• Clomiphene or enclomiphene to stimulate the HPG axis from the brain level
• Gradual dose reduction rather than abrupt cessation
• Regular blood work to track recovery of endogenous production

Men should be aware that stopping TRT often brings a temporary return of low-T symptoms while the body recalibrates. This period can last weeks to months and can be discouraging. Having a clear plan and realistic expectations helps [20].

Frequently Asked Questions

Is TRT the same as steroids?

Testosterone is an anabolic steroid by definition, but TRT uses physiological doses to restore normal levels, not supraphysiological doses to enhance performance. The intent, dosing, and medical supervision are what distinguish TRT from steroid abuse.

Will TRT cause prostate cancer?

Current evidence does not support the idea that TRT causes prostate cancer. The old fear was based on a misinterpretation of early data. The saturation model, proposed by Abraham Morgentaler, suggests that prostate tissue becomes saturated with androgens at relatively low levels, and adding more testosterone beyond that point does not increase prostate cancer risk [21]. However, TRT is contraindicated in men with active prostate cancer.

How quickly does TRT work?

Some benefits appear within weeks (energy, mood, libido), while others take months (body composition, bone density). Most men notice meaningful changes within 3 to 6 weeks, with continued improvement over 6 to 12 months.

Can I do TRT temporarily?

You can, but there are trade-offs. Short-term TRT will suppress your natural production, and it may take time to recover once you stop. If the underlying cause of low T is reversible (obesity, sleep apnea, medication side effects), addressing those factors first may raise testosterone without committing to long-term therapy.

Does TRT affect my heart?

The TRAVERSE trial (2023), the largest randomized controlled trial to date on testosterone and cardiovascular safety, found no increased risk of major adverse cardiovascular events in men with hypogonadism and preexisting or high cardiovascular risk. This was a reassuring finding, though ongoing monitoring of cardiovascular markers remains standard practice [15].

The Bottom Line

TRT can be a life-changing treatment for men with confirmed low testosterone. The improvements in energy, sexual function, body composition, and mood are well-documented and meaningful. But it is a medical treatment with real risks, ongoing monitoring requirements, and implications for fertility that need to be understood before starting.

Get proper testing. Work with a knowledgeable provider. Commit to regular lab work. And make the decision based on your own numbers and symptoms, not what someone on the internet told you changed their life.

References

1. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-01325
2. Salonia A, et al. European Association of Urology guidelines on sexual and reproductive health. Eur Urol. 2021;79(1):93-130. doi:10.1016/j.eururo.2020.06.032
3. Barbonetti A, et al. Testosterone replacement therapy. Nat Rev Urol. 2020;17(3):109-127. doi:10.1038/s41585-019-0162-4
4. Grossmann M. Hypogonadism and male obesity: focus on unresolved questions. Maturitas. 2016;92:18-25. doi:10.1016/j.maturitas.2016.02.016
5. Al-Futaisi AM, et al. Subcutaneous testosterone therapy: review of the literature. Andrology. 2016;4(5):775-779. doi:10.1111/andr.12357
6. Swerdloff RS, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000;85(12):4500-4510. doi:10.1210/jc.2009-2354
7. Pastuszak AW, et al. Pharmacokinetic profiles and acceptability of subcutaneous testosterone pellets. J Sex Med. 2017;14(3):413-421. doi:10.1016/j.jsxm.2017.01.009
8. Ramasamy R, et al. Effect of natesto on reproductive hormones, semen parameters, and hypogonadal symptoms. J Urol. 2019;202(6):1243-1248. doi:10.1016/j.juro.2019.01.085
9. Swerdloff RS, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Urol. 2020;204(1):129-137. doi:10.1016/j.juro.2019.09.091
10. Snyder PJ, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. doi:10.1056/NEJMoa1506119
11. Corona G, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013;98(2):3584-3593. doi:10.1210/jc.2010-0886
12. Walther A, et al. Association of testosterone treatment with alleviation of depressive symptoms in men. JAMA Psychiatry. 2019;76(1):31-40. doi:10.1001/jamapsychiatry.2018.2734
13. Snyder PJ, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. JAMA Intern Med. 2017;177(4):471-479. doi:10.1001/jamainternmed.2017.3869
14. Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. doi:10.1016/j.mayocp.2015.11.009
15. Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. doi:10.1056/NEJMoa2215025
16. Coviello AD, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Fertil Steril. 2005;83(3):722-726. doi:10.1016/j.fertnstert.2013.10.016
17. Wheeler KM, et al. Clomiphene citrate for the treatment of hypogonadism. Curr Urol Rep. 2016;17(2):25. doi:10.1007/s11930-015-0089-8
18. Kim ED, et al. Enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men. J Urol. 2015;193(4S):e315-e316. doi:10.1016/j.juro.2014.12.015
19. Davis SR, et al. Global consensus position statement on the use of testosterone therapy for women. J Sex Med. 2019;16(9):1331-1337. doi:10.1016/j.jsxm.2019.01.012
20. Kohn TP, et al. The effect of testosterone replacement therapy discontinuation and restart on semen parameters. Fertil Steril. 2019;112(3):e258. doi:10.1016/j.fertnstert.2019.05.032
21. Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009;55(2):310-321. doi:10.1016/j.eururo.2008.12.014

Related Reading

• Peptide Therapy: Types, Benefits, and What the Research Shows
• Hormone Replacement Therapy (HRT) for Women
• Sleep Optimization: Evidence-Based Strategies for Better Rest
• Functional Lab Testing: What to Test and Why